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Background: The criminal justice system (CJS), specifically prisons and jails, is ideally suited for uniform screening of
psychiatric (PD) and substance use disorders (SUDs) among people living with HIV/AIDS (PLWHA), who are
concentrated in these settings. By accurately diagnosing PDs and SUDs in these controlled settings, treatment can
be initiated and contribute to improved continuity of care upon release. In the context of PLWHA, it may also
improve combination antiretroviral treatment (cART) adherence, and reduce HIV transmission risk behaviors.
Methods: A retrospective data analysis was conducted by creating a cohort of PLWHA transitioning to the
community from prison or jail enrolled who were enrolled in a controlled trial of directly administered antiretroviral
(DAART). Participants were systematically assessed for PDs and SUDs using the Mini International Neuropsychiatric
Interview (MINI), a standardized psychiatric assessment tool, and compared to diagnoses documented within the
correctional medical record.
Results: Findings confirm a high prevalence of Axis I PDs (47.4%) and SUDs (67.1%) in PLWHA even after prolonged
abstinence from alcohol and drugs. Although prevalence of PDs and SUDs were high in the medical record, there
was fair to poor agreement among PDs using the MINI, making evident the potential benefit of more objective and
concurrent PD assessments to guide treatment.
Conclusions: Additional PD diagnoses may be detected in PLWHA in CJS using supplementary and objective
screening tools. By identifying and treating PDs and SUDs in the CJS, care may be improved and may ultimately
contribute to healthier outcomes after community release if patients are effectively transitioned.
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One in 100 adults in the United States (U.S.) is incar-
cerated, with one in 31 under community supervision
in parole or probation (Pew Center on the States 2009).
In the incarcerated population, HIV and psychiatric
disorders (PDs) are concentrated and syndemic, with
each negatively impacting the outcome of treatment
and prevention efforts. Axis I PDs and substance use* Correspondence: sandra.springer@yale.edu
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in any medium, provided the original work is pdisorders (SUDs) are concentrated among prisoners
within the criminal justice system (CJS), being two-fold
and 9-fold greater than found in the general population
(James et al. 2006; Substance Abuse and Mental Health
Services Administration 2011), respectively, as defined
by the 4th Diagnostic and Statistical Manual of Mental
Disorders (DSM-IV) (American Psychiatric Association.
Task Force on, D.-I 2000); similarly, the prevalence of
people living with HIV/AIDS (PLWHA) is 3- to 4-fold
greater within CJS than the general population, re-
spectively (Spaulding et al. 2009; Asner-Self et al. 2006;an Open Access article distributed under the terms of the Creative Commons
g/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction
roperly credited.
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involved PLWHA have higher rates of PDs than those
without HIV, and PDs are higher among this population
compared to those who are not incarcerated (Rich et al.
2011; Altice et al. 2010).
In the absence of HIV infection, PDs often remain un-
diagnosed and untreated due to a myriad of reasons
(Christiana et al. 2000; Holden et al. 2012; Draine et al.
2002; Link et al. 1997; Hines-Martin et al. 2003). It is es-
timated that 3 in every 5 persons with a mood, anxiety
or SUD do not seek professional help in the first year of
symptoms, moreover, it is common not to seek help for
up to 10 years after symptoms begin (Christiana et al.
2000). Furthermore, African Americans, who are dispro-
portionately concentrated in the CJS, are less likely than
Caucasians to seek help for PDs (Holden et al. 2012).
Prior treatment of PDs and psychiatric symptoms may
not be reported to healthcare professionals to avoid the
stigma associated with receiving a PD diagnosis (Link
et al. 1997). Additionally, in the presence of active sub-
stance use, inadequate diagnosis and treatment of PDs
in community settings unwittingly contribute to the
overburdened CJS (Draine et al. 2002), which struggles
with insufficient resources, yet these structured settings
makes them suitable for standardized screening and treat-
ment algorithms (Finkelstein et al. 2005; Maruschak and
Beavers 2009; Kamath et al. 2013). Consequences of
undiagnosed and under-treated PDs among PLWHA
can result in poor treatment outcomes for those transi-
tioning to the community where the highly structured
prison setting is discontinued, resulting in poor access and
adherence to combination antiretroviral therapy (cART)
(Springer et al. 2012; Meyer et al. 2011), suboptimal
viral suppression (Uldall et al. 2004; Springer et al.
2004; Meyer et al. 2011; Meyer et al. 2014) and increased
HIV risk-taking behaviors (Goforth and Fernandez
2011; Buckingham et al. 2013), repeated incarcerations
(Baillargeon et al. 2009; Baillargeon et al. 2010a; Baillargeon
et al. 2010b), relapse to drug and alcohol use (Krishnan
et al. 2013), decreased retention in HIV care (Althoff et al.
2013), a high frequency of emergency department
visits (Meyer et al. 2012, 2013), and a higher risk of
death (DeLorenze et al. 2010). Thus, correctly identi-
fying and treating PDs among HIV-infected prisoners
prior to release is crucial for effective transitional
care of PLWHA who re-enter the community (Springer
et al. 2011).
Given the negative consequences of PDs on HIV treat-
ment outcomes, we sought to investigate the prevalence
of DSM-IV PDs among a cohort of PLWHA prescribed
cART who were transitioning from prison to the com-
munity, assessed during a prolonged period of likely
abstinence from drugs and alcohol, and whether they
were diagnosed and treated.Methods
Participants
This was a retrospective data analysis of a previously
described prospective randomized controlled trial (RCT)
of directly administered antiretroviral treatment (DAART)
versus self-administered treatment (SAT) among HIV-
infected prisoners prescribed cART and with a pre-
incarceration history of heroin or cocaine use in the
6 months prior to incarceration who were transitioning
to the community. The details of the trial have been de-
scribed previously (Altice et al. 2011; Saber-Tehrani
et al. 2012), but briefly, 154 PLWHA participants pre-
scribed cART, age ≥18 years, and within 90 days of
release and returning to two areas in Connecticut (New
Haven or Hartford) upon release (F.L. Altice et al. 2011;
Saber-Tehrani et al. 2012) were recruited from 2004
through 2009. All participants underwent a baseline as-
sessment that included demographic characteristics,
drug use and addiction severity using the Addiction
Severity Index (ASI) (McLellan et al. 1992; Rikoon et al.
2006; McLellan et al. 2006), and the Mini International
Neuropsychiatric Interview (MINI) (Sheehan et al.
1997; D. V. Sheehan et al. 1998b; Amorim et al. 1998;
Lecrubier et al. 1997) assessed DSM-IV PDs in the ab-
sence of drug or alcohol use (>7 months) during incar-
ceration and prior to community release. Of the 154
recruited, 37 participants were excluded due to missing
data, either the clinical chart review (N = 21), the MINI
(N = 13) or both (N = 3) were missing, resulting in 117
participants included in the final analysis (Figure 1).
The parent study’s randomized intervention was con-
ducted after the baseline assessments were obtained,
therefore the intervention did not impact this particular
analysis.
Protections of human subjects
The parent study of DAART versus SAT (Altice
et al. 2011; Saber-Tehrani et al. 2012) was approved
by Yale University Human Investigation Committee
and Connecticut Department of Correction Research
Advisory Committee. Due to the inclusion of prisoners in
this study additional assurances were provided by the
Office of Human Research Protections and a Certificate
of Confidentially was obtained.
Measures of psychiatric disorders
After extensive training by developers of the MINI 5.0
computerized version, trained researchers administered
the MINI to participants while they were abstinent
from alcohol or drugs. It is a short diagnostic interview
with excellent reliability and validity for DSM-IV diag-
noses (Sheehan et al. 1997; D. V. Sheehan et al. 1998b;
Amorim et al. 1998; Lecrubier et al. 1997) and validated
to the Structured Clinical Interview (SCID-P) (Spitzer
Figure 1 Participant consort flow diagram.
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(CIDI) (Robins et al. 1988) for International Statistical
Classification of Disease (ICD-10) (D. Sheehan et al. 1997;
Sheehan et al. 1998b; Amorim et al. 1998; Lecrubier et al.
1997) with high construct validity and internal and ex-
ternal consistency. For this analysis, current (the past
12 months) and lifetime symptom diagnoses from se-
lected MINI 5.0 modules, were used as the “gold standard”
(Sheehan et al. 1997; Sheehan et al. 1998b; Amorim et al.
1998; Lecrubier et al. 1997).
For care and treatment, the Connecticut Department
of Correction (CTDOC) contracts the University of
Connecticut Health Center Correctional Managed Health
Care to follow a standardized Mental Health Policy (State
of CT Dept of Correction, 2008), which outlines the
screening and evaluation process. Intake screenings are
conducted by a licensed social worker or registered
nurse within 24 hours of referrals for: all first time in-
carcerations, those discharged from a psychiatric facility
within 30 days, those who display or indicate suicidalideation within 30 days of incarceration, inmates that
are indicated by the court or concerned party to have
mental health concerns, or inmates with either self or
concerned party reports of a history of suicide attempts
or plans within three years. Additionally, self-referrals
or referrals from concerned parties are evaluated within
72 hours (State of CT Dept of Correction 2008).
Through a class action lawsuit, additional mental health
screening is mandated for prisoners with HIV. Inmate
classification scores are used by the CTDOC to quantify
the severity of health care needs related to underlying PDs
ranging from 1 (no issues) to 5 (24-hour nursing needs).
(These classification scores are available at: http://www.ct.
gov/doc/lib/doc/PDF/PDFReport/ClassificationManual
LibraryCopy.pdf ). Although no standardized screening
tools are used, all HIV-infected prisoners are assessed fur-
ther by a licensed professional. After screening, triage to
other professionals for further assessment and treatment
is performed when indicated and the diagnoses noted
within the clinical record are used as the basis within
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nity medical records and those made within the CTDOC
and are noted as active or inactive.
Additional measures
Baseline characteristics included gender, age, ethnicity,
housing status, education level, randomization group
(DAART vs. SAT), drug use assessment of opioid or
cocaine use, hazardous drinking, participation in pre-
incarceration opioid substitution therapy and employment
status. All SUDs using the MINI or Alcohol Use Disorder
Identification Test (AUDIT) (Saunders et al. 1993;
Barbor 2001) assessed the 12-month time period before
the incarceration. Opioid and cocaine use disorders were
determined by using DSM-IV criteria for opioid or cocaine
dependence and abuse; alcohol use disorders were
assessed by the AUDIT, scores of eight or greater for men
or four or greater for women were used to define an alco-
hol use disorder (Bradley et al. 1998; National Institute on
Alcohol Abuse and Alcoholism 2005). Score for opioid,
cocaine and alcohol use disorders were coded dichotom-
ously. Additional drug use and addiction and psychiatric
symptom severity was ascertained using the ASI version
5 (McLellan et al. 1992) as well as psychiatric symptom
severity for the 30 days prior to incarceration. The ASI
composite drug (>0.16), alcohol (>0.17) and psychiatric
(>0.22) scores were reported as dichotomous variables
using cut-offs scores shown to have high levels of sensi-
tivity and specificity for DSM-IV diagnoses (Rikoon
et al. 2006; Calsyn et al. 2004).
Additional baseline characteristics collected from the
participant’s prison medical record included prescription
information for psychiatric medications, incarceration
dates, antiretroviral (cART) medications, and pre-release
HIV treatment status consisting of: HIV RNA viral load
(VL), and CD4 lymphocyte counts (CD4).
Analysis
Bivariate logistic regression analyses of the different psychi-
atric diagnosis by the MINI or medical record were used
to assess the differences in baseline demographic charac-
teristics. Statistical significance was defined at p < 0.05 for
all associations. Levels of agreement between the MINI
and medical record were calculated using Cohen’s Kappa
(Cohen 1960). Statistical analysis was conducted using
SPSS Version 19 (SPSS Inc., Chicago, IL, USA).
MINI diagnoses were compared to diagnoses re-
corded in the correctional medical record using logistic
regression. Diagnoses from both the MINI and medical
record were categorized into three major types of Axis I
disorders: mood, anxiety and thought disorders. Mood
disorders included current symptom diagnoses within
past 12 months of major depression and bipolar disor-
ders; anxiety disorders included current (past 12 month)symptom diagnosis of panic disorder, agoraphobia, obses-
sive compulsive disorder (OCD), post-traumatic stress
disorder (PTSD), generalized anxiety disorder (GAD),
and lifetime symptom diagnosis for panic disorder; and
thought disorders included psychotic disorder with and




Baseline characteristics (Table 1) demonstrated that par-
ticipants were primarily Black (53.8%) or Hispanic (32.5%)
men (82.1%) in their mid-40s. Over half (51.3%) antici-
pated unstable housing (with a family member or friend
temporarily, transitional housing, drug treatment facility,
or not knowing) or being homeless (24.2%: in a homeless
shelter or on the street) upon prison release. Clinically,
29.9% were prescribed psychiatric medications and all
were prescribed cART (most were prescribed a protease
inhibitor-based cART regimen [64.3%]), the majority
(78.6%) achieved viral suppression (VL < 400 copies/mL)
prior to release and had a mean CD4 of 403.6 cells/mL.
Prevalence of psychiatric disorders
Table 2 depicts the agreement of PD diagnoses made by
the MINI and medical record. Both the MINI (47.4%)
and medical record (44.8%) confirmed high prevalence
of having any PD; concordance between the two was
considered fair. Using the MINI, the prevalence of mood
disorders was 31.6% overall, with 12.8% of the full sam-
ple meeting criteria for major depressive disorder and
18.8% for bipolar disorder. Similarly, 31.0% met criteria
for having an anxiety disorder, with 14.7% having panic
disorder, 12.0% OCD, 6.9% PTSD and 11.2% GAD. Last,
11.1% of the sample met criteria of having a thought dis-
order, with 7.7% having a current psychotic disorder and
an additional 3.4% met criteria for lifetime psychotic
disorder.
While the prevalence of mood and thought disorders
was similar using the MINI and the medical record,
anxiety disorders were higher using the MINI (31.0%
versus 14.7%, p = 0.33). Among the subgroups of anxiety
disorders, the MINI diagnosed significantly more panic
disorders (14.7% vs. 0%, p < 0.001), and OCD (12.0% vs.
0%, p < 0.001) when compared to diagnoses documented
in the medical record.
Agreement of Psychiatric Disorder diagnoses
Despite that both the MINI and the medical record re-
view confirmed high levels of PD, the level of agreement
between the two was at best, fair, and mostly poor. The
highest (fair) level of agreement (kappa = 0.289) was
found for having any PD diagnosis suggesting being cor-
rectly diagnosed with a PD. When we further examined













Unstable Housing 60 (51.3%)
Homeless 29 (24.8%)
Stable Housing 21 (17.9%)
Opioid Use Disorder* 43 (36.8%)
Cocaine Use Disorder* 54 (46.2%)
Hazardous Drinking (AUDIT**) 50 (42.7%)
Viral Load (Baseline)
< 400 copies/mL 92 (78.6%)
< 50 copies/mL 66 (56.4%)
Mean Log HIV-1 RNA Level, cells/mL (SD) 2.300 (±1.02)
CD4+ lymphocytes count, cells/mL (SD) 403.61 (±244.4)
Addiction Severity Index Composite Scores
Psychiatric Composite Score (n=112)
Mean Severity Score (SD) 0.254 (±0.25)
High Severity (>.22) 52 (46.4%)
Drug Use Composite Score (n=113)
Mean Severity Score (SD) 0.085 (±0.08)
High Severity (>.16) 15 (13.3%)
Alcohol Use Composite Score (n=112)
Mean Severity Score (SD) 0.055 (±0.11)
High Severity (>.17) 8 (7.1%)
Prescribed Psychiatric Medications 35 (29.9%)
Anti-Depressants 22 (18.8%)
Anti-Psychotics 2 (1.7%)
Mood Stabilizers 1 (0.9%)
Multiple Medications 16 (13.7%)
Any Psychiatric Disorder (n=116)* 55 (47.4%)
Any Mood Disorder* 37 (31.6%)
Any Anxiety Disorder (n=116)* 36 (31.0%)
Any Thought Disorder* 13 (11.1%)
SD=standard deviation.
*Criteria for diagnosis defined by the Mini International Neuropsychiatric
Interview (MINI). Substance use disorders combine abuse and dependence
diagnosis criteria.
**Hazardous Drinking defined by the Alcohol Use Disorders Identification Test
(AUDIT), scores ≥8 for men, ≥4 for women.
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ever, levels of agreement decreased. Levels of agree-
ment for those diagnosed with a mood disorder
supported a fair level of agreement (kappa = 0.212),
however, there was considerable disagreement for major
depressive (kappa = 0.155) and bipolar (kappa = −0.052)
disorders, respectively.
Levels of agreement for any anxiety disorder (kappa =
0.081) or thought disorder (kappa = 0.096) were poor
and remained similarly low for each specific diagnosis
among the various anxiety and thought disorders
examined.
Co-morbidity of substance use disorders
Overall, SUDs were highly prevalent along with the vari-
ous PDs (Table 3). Using the MINI criteria, the prevalence
of any SUD among participants who also met criteria
for any Axis I PD were statistically significantly greater
(p = 0.007, CI 95% 1.331-6.202) than those without an
identified Axis I PD diagnosis (70.9% vs. 45.9%).
SUD co-morbidities among those who met criteria for
an anxiety disorder using the MINI or the medical record
were also high. Those with an anxiety disorder diagnosis
by the MINI or medical record versus those without a
diagnosis were statistically significantly more likely to
meet criteria for opioid use disorder (p = 0.021, CI 95%
1.150-5.435). Elevated, but non-statistically significant
differences were found for those with an anxiety dis-
order and having a concurrent cocaine or alcohol use
disorders.
Discussion
This study confirms high prevalence of both PDs and
SUDs among HIV-infected prisoners who are transi-
tioning to the community. It is imperative to accurately
identify and treat these disorders before release since
each can independently and negatively contribute to
poor post-release treatment outcomes if left untreated.
The aim of the study was to compare differences in
PD diagnoses when using a relatively quick and validated
DSM-IV screening tool, the MINI (Lecrubier et al. 1997;
D. V. Sheehan et al. 1998a; D. V. Sheehan et al. 1998b),
and compare findings to the medical record diagnosis of
PLWHA during incarceration when they are mostly free
from alcohol and drugs. Central to this study’s findings
is that it is challenging to make a PD diagnosis in the
setting of active drug or alcohol use, but all of the study
participants had been incarcerated for approximately
7 months and expect for unusual conditions, free from
alcohol or drugs. This is also the first English-language
study that examines the prevalence of Axis I PDs and
SUDs among a group of HIV-infected prisoners who are
transitioning to the community, and additionally compares
the diagnoses made during incarceration. The hypothesis
Table 2 Diagnoses Frequencies by Measure and Kappa Values









Any diagnosis (n=116) 55 (47.4%) 52 (44.8%) 42 (36.2%) 33 (28.4%) 0.294 Fair
Mood disorder 37 (31.6%) 34 (29.1%) 62 (53.0%) 16 (29.1%) 0.212 Fair
Major Depressive Disorder 15 (12.8%) 26 (22.2%) 82 (70.1%) 6 (24%) 0.155 Poor
Bipolar Disorder 22 (18.8%) 15 (12.8%) 82 (70.1%) 2 (5.7%) -0.052 Poor
Anxiety disorder (n=116) 36 (31.0%) 17 (14.7%) 70 (59.8%) 7 (15.2%) 0.081 Poor
Panic Disorder 17 (14.7%) 0 (0.0%) 99 (85.3%) 0 (0.0%) 0.000 Poor
Obsessive Compulsive
Disorder 14 (12.0%) 0 (0.0%) 103 (88.0%) 0 (0.0%) 0.000 Poor
Post-Traumatic Stress
Disorder 8 (6.9%) 13 (11.2%) 97 (82.9%) 1 (5%) 0.012 Poor
Generalized Anxiety 13 (11.2%) 5 (4.3%) 99 (85.3%) 1 (5.9%) 0.052 Poor
Thought disorder 13 (11.1%) 16 (13.7%) 91 (77.8%) 3 (11.5%) 0.096 Poor
Table 3 Prevalence of Co-Morbidity of Substance Use and Psychiatric Disorders
Tool used for diagnosis Regression results forany disorder diagnosis










Hazardous Drinking 25 (48.1%) 24 (46.2%) 17 (40.5%) 1.207 (0.557-2.615)
Opioid Use Disorder 15 (28.8%) 24 (46.2%) 13 (31.0%) 1.521 (0.682-3.392)










Hazardous Drinking 19 (51.4%) 18 (52.9%) 22 (35.5%) 1.035 (0.467-2.293)
Opioid Use Disorder 15 (40.5%) 16 (47.1%) 21 (33.9%) 1.250 (0.558-2.802)










Hazardous Drinking 15 (41.7%) 10 (58.8%) 27 (38.6%) 1.668 (0.774-3.595)
Opioid Use Disorder 17 (47.2%) 12 (70.6%) 20 (28.6%) 2.500* (1.150-5.435)










Hazardous Drinking 9 (69.2%) 8 (50%) 36 (40.9%) 0.593 (0.699-4.064)
Opioid Use Disorder 7 (53.8%) 6 (37.5%) 32 (35.2%) 1.352 (0.556-3.289)
Cocaine Use Disorder 9 (69.2%) 5 (31.3%) 42 (46.2%) 1.000 (0.417-2.397)
OR: Odds Ratio.
Hazardous Drinking defined by the Alcohol Use Disorders Identification Test (AUDIT), scores ≥8 for men, ≥4 for women (N=113).
Opioid and Cocaine Use Disorder defined by DSM-IV criteria via the Mini International Neuropsychiatric Interview (MINI) for abuse and dependence.
*p<0.05.
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the two measures and we found a fair level of agreement
between the MINI and prison medical record for those
with any PD, and fair to poor degrees of concordance be-
tween the three major categories explored in this analysis.
The prevalence of mood disorders was similar based be-
tween the MINI and medical record (31.6% and 29.1%),
but of those, only 28.6% were diagnosed using both mea-
sures. Anxiety disorder diagnoses were found to be differ-
ent between the measures (MINI 31.0% vs. 14.7% medical
record), however, and only 15.2% of individuals shared a
diagnosis using both assessments. Similarly, the prevalence
of thought disorders was 11.1% using the MINI vs. 13.7%
using the medical record, with a mutual concordant
diagnosis of only 11.5% from both measures. The prison
medical record diagnoses matched moderately well with
the MINI, thus suggesting that the prison system does a
reasonable job in screening for PD among the inmates,
although the kappa values suggest that significant im-
provements can be made for certain diagnoses.
Given the continuous concern of suicide among pris-
oners, screening questions that focus on measuring
suicidal ideation, depression and psychosis and less on
anxiety and thought disorders, may explain the higher
rates of agreement for mood disorders versus the other
disorders. Despite the staff and budget limitations of
prisons, correctional facilities are able to improve and
maintain the health of the inmates by directly adminis-
tering the inmate’s medications, providing increased
medical attention, having access to support from staff
and the general structure of prisons thus allowing inmates
to live a more organized life. Extensive efforts have created
a system to improve successful linkage of PLWHA upon
release from prisons to appropriate community services,
enabling continuity of care including the possible continu-
ation of directly administered medications, for not only
for cART but all medications, including psychiatric medi-
cations. Findings here, however, support the integration of
HIV and psychiatric care for transitional care programs.
The prevalence of mood disorders by either measure
in this study is high when compared to 6.8% in the general
population (Reeves et al. 2011), and some other correc-
tional systems like in Texas where only 11.0% had re-
ported diagnoses of major depressive, bipolar, non-
schizophrenic psychotic disorders or schizophrenia
(Baillargeon et al. 2009). Similarly, 12.3% of U.S. adults
report a lifetime diagnosis of an anxiety disorder, with
higher prevalence among women and non-Hispanic
white groups (Reeves et al. 2011); much lower than the
rate of 31.0% found in this analysis. Additionally, this
analysis found an astounding prevalence of bipolar dis-
order (18.8%) compared to 1.7% nationally (Reeves
et al. 2011). Given the likely impulsivity of those with
poorly controlled bipolar disorder and its contributionto SUDs, a targeted treatment plan to stabilize this
population during incarceration and post-release to the
community may improve retention in care, reduce relapse
to drug and alcohol use and decrease HIV risk behaviors.
Importantly, properly diagnosing bipolar disorder has im-
portant implications since treatments differ from other
mood disorders. The prevalence in this study was also
greater than those found in a different study of the Texas
prisoners using the diagnosis of PDs solely from the
medical record (Baillargeon et al. 2009) where only
11.0% of 71,333 Texas inmates were diagnosed with a
PD (Baillargeon et al. 2009); and higher prevalence of
PDs among HIV-infected when compared to their HIV
negative counterparts (Baillargeon et al. 2003). Overall
there appears to be variance of reported PD diagnosis
among prisoners in other studies, which may be due to
the type of diagnostic screening tool utilized by correc-
tional facilities line in Texas (Baillargeon et al. 2009;
Baillargeon et al. 2003).
Although this study was specific to PLWHA, it is well
known that PD are very common among all persons
with the CJS including HIV uninfected persons. Thus
likely improving accuracy of diagnosis of PD will improve
care not only among PLWHA but also for all persons
within the CJS and post-release (Brink 2005). The MINI is
not a gold standard over a trained psychiatric assessment
of psychiatric disorders, but given the high concentration
of PDs in the U.S. prisons, a standardized psychiatric
diagnostic screening tool that can be administered
quickly and accurately would enhance existing screening
policies. Additionally, screening during every new ad-
mission could identify new symptoms of PD, allowing
the facility to initiate treatment and arrange for continued
treatment upon release. A single screening upon intake
especially for those coming directly from the community
where active drug or alcohol use, however, could compli-
cate diagnostics and might lead to inaccurate diagnoses.
Thus, innovative strategies that make acute PD diagnoses
followed by assessments after periods of abstinence might
better serve prisoners. For the duration of incarceration
and after release, treatment of PD can increase cART
adherence (Blower et al. 2000), and reduce sexual risk
behavior (Kalichman 2008). Increased surveillance, treat-
ment and continued care may also have implications for
reduced PD symptoms thereby reducing relapse and rein-
carceation (Fu et al. 2013). As a result, it may also improve
the safety of the community and potentially reduce the
risk of HIV transmission by reducing risk behaviors
(Spaulding et al. 2002).
Important in this analysis is the high prevalence of PD
among HIV-infected prisoners transitioning to the com-
munity. Although standard PD screening algorithms in
prisons identified many diagnoses, some were not identi-
fied and others were incorrectly diagnosed. While not all
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constraints (costs for the proprietary screening instru-
ment or staff time required to administer it), brief and
accurate validated screening and diagnostic instruments
for PDs should be considered to consistently identify the
PD to offer appropriate treatment and later refer to
community resources upon release. Such validated PD
screens developed specifically for CJS exist (Ford et al.
2009; Steadman et al. 2005) and can serve as a first stage
in an efficient diagnostic process. Correctly identifying
Axis I PDs and SUDs is of high importance for CJS-
involved patients, while alternative ways to improve psy-
chiatric treatment continue to be pursued. The calculus
is heightened especially for PLWHA who also must
transition effectively to the community. The transition
from correctional facility to the community has been
shown to be a troublesome time; and it has been shown
that PD is a factor in reincarceration (Binswanger et al.
2007; Baillargeon et al. 2010a; Fu et al. 2013). A focused
treatment plan during their incarceration and after re-
lease is an important opportunity to reduce this risk that
should include screening to identify PDs.
Strengths and limitations
To our knowledge, this is the first study evaluating a spe-
cific DSM-IV disorder validated tool to evaluate prison-
based psychiatric diagnoses among HIV-infected prisoners.
By conducting this analysis we are able to begin to con-
struct a single state system image of the current state of
the mental health of HIV-infected prisoners, and find areas
to improve comprehensive care. Limited within this evalu-
ation, however, is the retrospective nature of this study
among PLWHA in the CT CJS and a sample size that was
not determined a priori to support this analysis, and limits
the generalizability. Additionally, limited data were avail-
able to contribute to the different PD diagnoses including
their association with criminal justice history. Nonetheless,
it demonstrated high levels of PDs and SUDs in this popu-
lation. The MINI 5.0 version used in this analysis did not
include lifetime diagnosis criteria for all of the PDs, there-
fore the diagnosis of bipolar disorder becomes challenging
given that there may be symptoms that have not mani-
fested within the 12 months of pre-release assessment
(potentially reducing the apparent prevalence). For those
subjects incarcerated less than one year, there is also con-
cern for confounding SUDs that may have masked or
mimicked some symptoms as well. Additionally, a major-
ity of the participants in the analysis have a history of prior
incarcerations, and therefore it is likely that the diagnoses
in the medical records may be older than the MINI diag-
noses. In this context, the current sample diagnosed with
a mood disorder had a co-morbid diagnosis of cocaine use
disorder 54.1% and opioid use disorder 40.5%. Additional
research is needed in this area to explore brief, validatedscreening instruments for PD to improve early identifica-
tion, initiate appropriate psychiatric treatment and ensure
continuity of care post-release in order to guide integrated
care efforts for PLWHA with multiple co-occurring disor-
ders as they transition to the community (Ford et al. 2009;
Steadman et al. 2005).
Conclusions
A consistent screening and assessment protocol for all
DSM-IV PDs in the CJS may improve care in the facilities
and with proper referrals, may improve retention in care
upon release. Given that all PLWHA are now recom-
mended to initiate cART, such strategies should have great
impact on HIV treatment as prevention efforts (Montaner
2013). Those with PDs increase the burden of care in
prisons and the community upon release. Addressing the
issue of identification and appropriate treatment for PDs
in a controlled environment such as during incarcer-
ation can have implications within correctional facilities
and later in the community. Given the recent release of
DSM-V, this would be an ideal time for all correctional
facilities and community supervision program to evalu-
ate their current policies regarding PDs screening and
treatment. Further research is needed in this area to
examine the full implications of increased screening for
PDs among PLWHA.
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